论文部分内容阅读
在当前的条件下,对于一个真正的艾滋病(AIDS)患者来说,由于人类免疫缺乏病毒(H-IV)的核酸永远与宿主细胞结合在一起,机体无法消除病毒,致使人体防御细胞几乎完全遭到破坏,感染连绵不断,治疗十分棘手。除加强预防外,寻求治疗AIDS的有效药物是各国医学界为征服AIDS而努力的一个重要方面。应用静脉内注射免疫球蛋白(IVIG)治疗AIDS,就是这种努力的一部分。尽管这利治疗的结果是初步的,但由于至今尚无治疗A-IDS的特效药物,仍引起临床医生和有关研究人员的重视。1986年3月,瑞士红十字会输血服务部中心实验室召集了一次以此为主题,有
Under the current conditions, for a true AIDS patient, the body’s inability to eliminate the virus, resulting in the almost complete destruction of human defensive cells, is due to the permanent association of the human immunodeficiency virus (H-IV) nucleic acid with the host cell To destruction, continuous infection, treatment is very difficult. In addition to strengthening prevention, effective medicines that seek treatment for AIDS are an important aspect of the medical community’s efforts to conquer AIDS. The use of intravenous immunoglobulin (IVIG) to treat AIDS is part of that effort. Although the benefit of this treatment is preliminary, it still attracts the attention of clinicians and researchers due to the lack of effective drugs for the treatment of A-IDS. In March 1986, the Swiss Red Cross Center for Blood Transfusion Service convened a conference on the theme of